ABUS Surged 87% on $2.25 Billion Moderna Settlement — RTPR Had the Wire in 341ms
ABUS gained 87% after a $2.25B Moderna settlement was announced. RTPR delivered the Business Wire release in 341ms.
Arbutus Biopharma (NASDAQ: ABUS) gained 87% on March 3, 2026, after Business Wire published a press release announcing a $2.25 billion global settlement with Moderna. RTPR delivered the wire in 341 milliseconds.
The Catalyst
The press release, titled "Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna," disclosed the resolution of ongoing intellectual property disputes related to lipid nanoparticle technology used in Moderna's mRNA vaccines.
For context on why the stock moved as sharply as it did: Arbutus had a market capitalization of approximately $280 million before the announcement. A $2.25 billion settlement — even split with Genevant Sciences — represents a cash inflow many times larger than the company's prior enterprise value.
Settlement proceeds of this magnitude relative to market cap typically produce large intraday moves in small-cap biotech stocks, and this case followed that pattern.
RTPR Speed Callout RTPR delivered the wire in 341ms. Free aggregators typically show Business Wire releases 2–4 minutes after publication.
ABUS traded at $4.75 when the wire hit. The stock peaked at $8.35 — an 87% gain from the wire price — before pulling back.
What Moved the Stock
Large legal settlements in biotech often produce outsized reactions because they convert years of uncertain litigation into a defined cash amount. In this case, the settlement resolved Moderna-related IP claims that had been a source of both risk and potential upside for Arbutus shareholders.
The math was straightforward: a company with a $280 million market cap announced it would receive a significant portion of $2.25 billion. Traders who saw the headline early had a window to act before the price reflected the news.
Want This Speed?
RTPR delivers press releases from Business Wire, PR Newswire, GlobeNewswire, and AccessWire in under 500ms — typically 2-4 minutes before free sources.
- Pricing and plans: https://rtpr.io/pricing
- API documentation: https://rtpr.io/docs